{"url_path":"/sec/vsee/8-k/2026-06-05/item-1-01","section_key":"item-1-01","section_title":"Item 1.01 ****Entry","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-05","source_url":"https://www.sec.gov/Archives/edgar/data/1864531/0001185185-26-002359-index.html","accession_number":"0001185185-26-002359","cik":"0001864531","ticker":"VSEE","issuer_name":"VSEE HEALTH, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1864531/0001185185-26-002359-index.html","primary_entity_key":"0001864531","primary_entity_name":"VSEE HEALTH, INC."},"word_count":425,"has_tables":true,"body_markdown":"**Item\n1.01****Entry\ninto a Material Definitive Agreement.**\n\n** **\n\nOn\nMay 31, 2026, VSee Health, Inc., a Delaware corporation (the “Company”) entered into a Stock Purchase Agreement (the “Purchase\nAgreement”) with Milton Chen, the Company’s co-Chief Executive Officer and Chairman of the Board and the Chief Executive\nOfficer of VSee Lab, Inc., a Delaware Corporation and wholly-owned subsidiary of the Company (“VSee Lab”). Pursuant to the\nPurchase Agreement, Mr. Chen agreed to purchase, and the Company agreed to sell to Mr. Chen, on the May 31, 2026 (the “Closing\nDate”), all of the equity securities of VSee Lab (the “VSee Lab Stock”), free and clear of all liens and encumbrances.\nUnder the Purchase Agreement, Mr. Chen is solely responsible for causing the Company to satisfy any and all indebtedness and other liabilities\nof VSee Lab that are not paid as of the closing contemplated by the Purchase Agreement (the “Closing”) and the Company will\nhave no obligation with respect thereto. Notwithstanding, the Company will retain, pay, perform and discharge and remain solely responsible\nfor, any and all liabilities, obligations or commitments of VSee Lab or relating to the ownership or operation of VSee Lab related to\nany period, event, circumstance or condition occurring prior to the Closing Date, including any liabilities relating to taxes for any\nand all taxes attributable to any taxable period ending on or before the Closing Date and the portion through the Closing Date for any\ntaxable period that includes, but does not end, on the Closing Date, other than sales and use taxes accrued at the company level, which\nwill remain an obligation of VSee Lab, regardless of the time period of when such obligation were incurred and except to the extent expressly\nassumed by Mr. Chen pursuant to the Purchase Agreement.\n\n \n\nIn\nconsideration for the VSee Lab Stock and the mutual release of liability set forth in the Purchase Agreement, Mr. Chen has agreed to\ntransfer to the Company all of the common stock, par value $0.0001 per share (the “Common Stock”), of the Company that he\ncurrently owns, or 2,870,069 shares of Common Stock. In connection with the execution of the Purchase Agreement, Mr. Chen resigned as\nco-Chief Executive Officer and chairman of the board of directors of the Company, effective as of the Closing Date.\n\n \n\nThe\nforegoing description of the Purchase Agreement does not purport to be complete and is qualified in its entirety by reference to the\nPurchase Agreement, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference."}